Community Practice

On Tuesday, California Governor Gavin Newsom granted California pharmacists the ability to order and administer coronavirus disease 2019 (COVID-19) tests.

A presentation from the 2020 PQA Annual Meeting discussed the emerging focus on social determinants of health within the industry and how pharmacists can address the issue.

Purdue University College of Pharmacy in West Lafayette, Indiana, helped its students graduate in record time this spring.

Nearly 94% of survey respondents agreed that provider status is important for the future of pharmacy.

Officials with the FDA granted Emergency Use Authorization (EUA) to the first diagnostic test that will allow at-home collection of saliva samples for coronavirus disease 2019 (COVID-19) testing.

The letter to congressional leaders warned that without reform, vulnerable populations could lose access to pharmacies, which are the first point-of-care for many.

The FDA recently added famotidine to its list of drug shortages.

The campaign will feature testimonials from patients of the COVID-19 pandemic’s “unsung heroes.”

A recent study included interviews with pharmacists in rural Kentucky counties regarding pharmacy-level barriers to opioid use disorder treatment.

115 members of the House have come out in support of eliminating DIR fees in future coronavirus relief packages.

To date, 19 states have authorized pharmacists to order and conduct testing for COVID-19.

In part 2 of our video interview, Doug Hackenyos, oncology pharmacy clinical coordinator at the University of Connecticut, discusses the effects of COVID-19 on cancer care pharmacy.

Guidance includes recommendations for pharmacies providing COVID-19 testing, vaccinations.

If health care were a country, it would be the fifth largest emitter of greenhouse gases worldwide.

“The reality is that pharmacy workers are smack dab in the middle of trauma.”

Early treatment of shingles reduces symptoms and risk of serious complications.

Eighty-eight percent of community pharmacy owners reported intentions to apply for COVID-19 federal aid, such as provisions from the CARES Act, according to the survey

Pharmacist reminders boost shingles vaccination compliance.

“Pharmacists are the safety net for their communities…we must ensure that these pharmacies have access to the tools they need to fight this pandemic and continue being there for patients in the future.”

Insulin manufacturers are expanding insulin affordability options for patients with diabetes during the coronavirus pandemic. 

As the global COVID-19 pandemic and consequent public health crisis continues on, health care providers on the frontlines of this crisis deserve all of the support needed to continue serving their patients.

In an opinion piece published in the Annals of Internal Medicine, community pharmacists were credited with helping to mitigate the spread of coronavirus throughout Taiwan.

OmniSYS is providing all pharmacies free access to the OmniSYS Training Center™, which guides pharmacists through all aspects of the process to operationalize COVID-19 testing

“I had been practicing for 4 years at that time and longed for the day that pharmacists would have input in patient’s pharmacotherapy. That day is here!”

Pharmacists are positioned to play a key role in preventing or catching errors that can occur at the various stages of the drug-use process: prescribing, dispensing, and administration.

Expanding COVID-19 testing is "a critical component in our nation's efforts to reduce the number of cases, ease burdens on our over-utilized hospitals and clinics, and protect the safety of our communities," the Pharmacists for Healthier Lives coalition said.

Pharmacies that haven’t added digital marketing and advertising to their mix are missing the target.

Pharmacists can play an integral role in managing patients with diabetes.

Cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is no longer considered a controlled substance.

Pharmacies, just as expected, have showed up in meaningful ways to support their communities.